TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$95.8M 3.37%
416,560
-191,658
2
$95.3M 3.35%
264,703
-24,221
3
$86.7M 3.05%
179,385
-28,003
4
$86.1M 3.02%
546,805
5
$81.9M 2.88%
1,405,371
-238,312
6
$78.4M 2.76%
501,942
+235,151
7
$76.9M 2.7%
219,185
+33,450
8
$72.2M 2.54%
305,310
-96,050
9
$66.4M 2.33%
619,759
-254,961
10
$62.7M 2.2%
534,914
11
$61.4M 2.16%
989,908
+44,768
12
$60.4M 2.12%
246,844
+33,091
13
$59.4M 2.09%
127,553
+98,092
14
$51.4M 1.81%
293,619
-43,585
15
$48.8M 1.72%
247,980
+171,764
16
$47.2M 1.66%
431,145
+61,572
17
$45.9M 1.61%
587,826
-519,602
18
$40.1M 1.41%
237,537
+59,900
19
$37.6M 1.32%
153,330
-4,500
20
$35.2M 1.24%
206,487
21
$34M 1.2%
465,016
-138,668
22
$34M 1.19%
82,807
-3,200
23
$33M 1.16%
220,434
+22,739
24
$33M 1.16%
135,016
25
$28.8M 1.01%
175,097
+93,164
1
2 3 4 5